Choreo LLC Invests $134,000 in LifeStance Health Group, Inc. (NASDAQ:LFST)

Choreo LLC bought a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 26,850 shares of the company’s stock, valued at approximately $134,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Arizona State Retirement System raised its position in shares of LifeStance Health Group by 22.9% during the 2nd quarter. Arizona State Retirement System now owns 31,972 shares of the company’s stock worth $157,000 after acquiring an additional 5,959 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of LifeStance Health Group by 27.0% during the 2nd quarter. Victory Capital Management Inc. now owns 14,407 shares of the company’s stock worth $71,000 after acquiring an additional 3,063 shares in the last quarter. TD Asset Management Inc acquired a new stake in shares of LifeStance Health Group during the 2nd quarter worth about $623,000. Rhumbline Advisers raised its position in shares of LifeStance Health Group by 17.6% during the 2nd quarter. Rhumbline Advisers now owns 182,131 shares of the company’s stock worth $894,000 after acquiring an additional 27,280 shares in the last quarter. Finally, CIBC Asset Management Inc acquired a new stake in shares of LifeStance Health Group during the 2nd quarter worth about $53,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Trading Down 0.7 %

NASDAQ:LFST opened at $6.81 on Friday. The stock’s 50 day moving average price is $6.03 and its 200 day moving average price is $6.04. LifeStance Health Group, Inc. has a 52-week low of $4.64 and a 52-week high of $9.20. The company has a market capitalization of $2.60 billion, a PE ratio of -14.19 and a beta of 1.22. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.20.

LifeStance Health Group (NASDAQ:LFST) last announced its earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. LifeStance Health Group had a negative return on equity of 10.51% and a negative net margin of 13.05%. The company had revenue of $312.30 million for the quarter, compared to the consensus estimate of $305.85 million. During the same period last year, the business posted ($0.13) EPS. The company’s revenue was up 20.3% on a year-over-year basis. On average, research analysts anticipate that LifeStance Health Group, Inc. will post -0.24 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on LFST. UBS Group cut their target price on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a research report on Thursday, August 15th. Barclays dropped their price target on LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating on the stock in a research note on Friday, August 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $8.25.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, insider Ann Varanakis sold 5,269 shares of LifeStance Health Group stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $6.28, for a total value of $33,089.32. Following the transaction, the insider now directly owns 263,007 shares in the company, valued at approximately $1,651,683.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 6.60% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.